NCT02351635 - BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS | Biotech Hunter

Enrollment

478

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

April 30, 2018

Conditions

Inflammatory Bowel DiseaseIrritable Bowel Syndrome

Interventions

OTHER

fecal calprotectin level

Stool sample collected by the subject, sent study laboratories where fecal calprotectin levels are quantified.

Trial Locations (7)

Gastroenterology Associates of Tidewater, Chesapeake

Gastroenterology Assocaites of Central Georgia, Macon

Gastro Health, Miami

Great Lakes Gastroenterology Research, LLC., Mentor

Carle Foundation, Center for Digestive and Liver Disease, Urbana

Stanford Center for Clinical & Translational Research & Education, Palo Alto

Beth israel Deaconess Medical Center, Boston